AI assistant
Sending…
Cellcom Israel Ltd. — Remuneration Information 2020
Jul 26, 2020
6724_rns_2020-07-26_3acd1fda-3f1a-47fd-9039-67c64a0fa5bb.htm
Remuneration Information
Open in viewerOpens in your device viewer
CELLCOM ISRAEL ANNOUNCES CHANGES TO COMPENSATION POLICY AND INDEMNIFICATION AND EXEMPTION LETTERS INCLUDED ON AGENDA OF JULY 27, 2020 ANNUAL SHAREHOLD false
| ����� ����� ��"� | 2 380 |
| CELLCOM ISRAEL LTD | |
| Corporation no: 511930125 | 5180 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 26/07/2020 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2020-02-079089 | Time of broadcast: 20:18 19:50:08 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onCELLCOM ISRAEL ANNOUNCES CHANGES TO COMPENSATION POLICY AND INDEMNIFICATION AND EXEMPTION LETTERS INCLUDED ON AGENDA OF JULY 27, 2020 ANNUAL SHAREHOLDER MEETING AND POSTPONEMENT OF ANNUAL SHAREHOLDER MEETING TO AUGUST 12, 2020
PR_Postponement_of_AGM_2020_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NYSE | Date of revision of form structure: 23/06/2020 |
| Address: Hagavish 10 , Netanya 42140 , Tel: 052-9989595 , Fax: 09-8607986 | |
| E-mail address: [email protected] | |
| Previous names of reporting entity: | |
| Name of the Signatory: Menahemi Stadler Liat Position of Signatory in the reporting corporation: VP Chief Legal Counsel and Company Secretary Name of Employer Company: | |
| Address: Hagavish 10 , Netanya 42140 Telephone: 052-9989595 Facsimile: 09-8607986 E-mail: [email protected] 1 | |
More from Cellcom Israel Ltd.
Interim / Quarterly Report
2026
May 20
Interim / Quarterly Report
2026
May 20
Interim / Quarterly Report
2026
May 20
Board/Management Information
2026
May 20
Director's Dealing
2026
May 20
Investor Presentation
2026
May 20
Report Publication Announcement
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Share Issue/Capital Change
2026
May 20